1. Home
  2. Live Updates
  3. நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம்

Page 7 - நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் Today - Breaking & Trending Today

About 8,000 volunteers received placebo during Sputnik V trials, says expert


About 8,000 volunteers received placebo during Sputnik V trials, says expert
Earlier, the press service of the Russian Healthcare Ministry reported that the ministry made a decision not to recruit volunteers for vaccine trials anymore
© Sergei Karpukhin/TASS
MOSCOW, December 23. /TASS/. About 8,000 volunteers out of almost 32,000 who participated in trials of the Sputnik V vaccine against the novel coronavirus have received a placebo instead of the preparation, Head of the Department of Clinical Pharmacology and Therapy, Vice-Chancellor of the Russian Medical Academy of Continued Professional Education Dmitry Sychev told journalists on Wednesday.
Earlier, the press service of the Russian Healthcare Ministry reported that the ministry made a decision not to recruit volunteers for vaccine trials anymore. ....

Russian Healthcare Ministry , Head Of The Department Clinical Pharmacology , Gamaleya National Research Center , Microbiology Of The Russian Healthcare Ministry , Clinical Pharmacology , Russian Medical Academy , Continued Professional Education Dmitry Sychev , American Moderna , ரஷ்ய சுகாதாரம் அமைச்சகம் , தலை ஆஃப் தி துறை மருத்துவ மருந்தியல் , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் , மருத்துவ மருந்தியல் , ரஷ்ய மருத்துவ கலைக்கழகம் , அமெரிக்கன் மாடர்னா ,

Malaysia plans to get Russia's Sputnik V vaccine, prime minister says - Society & Culture


Malaysia plans to get Russia’s Sputnik V vaccine, prime minister says
Malaysia’s authorities also signed a deal on purchasing 6.4 mln doses of a coronavirus vaccine produced by British-Swedish pharmaceutical company AstraZeneca, Prime Minister Muhyiddin Yassin said
© Elena Afonina/TASS
SINGAPORE, December 22. /TASS/. Malaysia’s authorities signed a deal on purchasing 6.4 mln doses of a coronavirus vaccine produced by British-Swedish pharmaceutical company AstraZeneca and also expect Russia’s Sputnik V, Prime Minister Muhyiddin Yassin said in his televised speech on Tuesday.
The Vaccine Supplies Access Guarantee Special Committee, co-chaired by the Health Minister and the Science, Technology and Innovation Minister, will ensure the vaccines could be acquired fast, he said. The government is also in the final stage of negotiation with Sinovac, CanSino and Gamaleya [Sputnik V producer] to secure vaccine supply. ....

United Kingdom , Muhyiddin Yassin , Gamaleya National Research Center , Microbiology Of The Russian Healthcare Ministry , Vaccine Supplies Access Guarantee Special Committee , Prime Minister Muhyiddin Yassin , Health Minister , Innovation Minister , Russian Healthcare , ஒன்றுபட்டது கிஂக்டம் , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் , தடுப்பூசி பொருட்கள் நுழைவு உத்தரவாதம் சிறப்பு குழு , ஆரோக்கியம் அமைச்சர் , கண்டுபிடிப்பு அமைச்சர் , ரஷ்ய சுகாதாரம் ,

Sputnik V trials on people over 60 may be completed this week


Sputnik V trials on people over 60 may be completed this week
On August 11, Russia became the first country worldwide to register a vaccine against the coronavirus which was named Sputnik V
MOSCOW, December 21. /TASS/. Trials of the Sputnik V vaccine against the coronavirus on volunteers over 60 years of age may be completed by the end of this week, Russian Healthcare Minister Mikhail Murashko said in an interview with the Russia-24 TV channel.
Read also
Now they are already being completed, these are the last days of clinical trials of a vaccine on individuals over 60 years of age. We hope that at some point after [December] 23rd - 24th the trials proper will be over, the documents will be assessed by experts and a review of indications will take place, he said. ....

Gamaleya National Research Center , Microbiology Of The Russian Healthcare Ministry , Russian Healthcare , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் , ரஷ்ய சுகாதாரம் ,

AstraZeneca and Sputnik V investor and developer sign agreement of cooperation on vaccines


AstraZeneca and Sputnik V investor and developer sign agreement of cooperation on vaccines
The sides agreed to boost research and business relations that will include studies to explore the potential of a combined use of the Russian Sputnik V vaccine and the AZD1222 preparation developed by the British-Swedish AstraZeneca
Participants in a meeting on the signing of a Memorandum of Intent in the area of preventing the novel coronavirus infection between the Gamaleya National Research Center for Epidemiology and Microbiology, AstraZeneca, RDIF and R-Pharm © Alexei Nikolsky/Russian presidential press service/TASS
MOSCOW, December 21. /TASS/. The Russian Direct Investment Fund (RDIF), the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry and the AstraZeneca and R-Pharm pharmaceutical companies have signed an agreement on development and implementation of a program of clinical trials of a combination of vaccines aga ....

United Kingdom , Vladimir Putin , Gamaleya National Research Center , Microbiology Of The Russian Healthcare Ministry , Russian Healthcare Ministry , Russian President Vladimir Putin , British Swedish Astrazeneca , ஒன்றுபட்டது கிஂக்டம் , விளாடிமிர் புட்டின் , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் , ரஷ்ய சுகாதாரம் அமைச்சகம் , ரஷ்ய ப்ரெஸிடெஂட் விளாடிமிர் புட்டின் ,

Russia plans to vaccinate elderly people against COVID-19 next week


Russia plans to vaccinate elderly people against COVID-19 next week
According to the country’s Health Minister Mikhail Murashko, the vaccine’s clinical trials on people aged above 60 are now nearing end
© Kirill Kukhmar/TASS
MOSCOW, December 20. /TASS/. Russia plans to vaccinate people above 60 years of age against COVID-19 next week, the country’s Health Minister Mikhail Murashko announced in an interview with the news program on Rossiya-1 TV channel on Sunday.
Yes, we hope so, the health minister stated in response to the question, whether the elderly people’s vaccination could begin next week.
According to him, the vaccine’s clinical trials on people aged above 60 are now nearing end. ....

Stavropol Skiy Kray , Mikhail Murashko , Chumakov Federal Scientific Center , Gamaleya National Research Center , Vector State Research Center , Products Of The Russian Academy Sciences , Microbiology Of The Russian Healthcare Ministry , Health Minister Mikhail Murashko , Russian Healthcare , Novosibirsk Based Vector State Research Center , Federal Service , Consumer Rights Protection , Human Wellbeing , Biological Products , Russian Academy , திசையன் நிலை ஆராய்ச்சி மையம் , ப்ராடக்ட்ஸ் ஆஃப் தி ரஷ்ய கலைக்கழகம் அறிவியல் , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் , ரஷ்ய சுகாதாரம் , கூட்டாட்சியின் சேவை , நுகர்வோர் உரிமைகள் ப்ரொடெக்ஶந் , மனிதன் நல்வாழ்வு , உயிரியல் ப்ராடக்ட்ஸ் , ரஷ்ய கலைக்கழகம் ,